R&D
In conversation with Chris Moore: Declining HCP access
During the 10th anniversary of the Veeva R&D and Quality Summit, held …
19707 items found
News
Valneva gets $41m grant to roll out chikungunya vaccine
Valneva has been awarded funding from the Coalition for Epidemic …
News
Study finds wearables deliver key insights in heart disease
Off-the-shelf consumer wearables have shown a benefit when used to …
News
Innovent throws its hat further into China's GLP-1 ring
Innovent Biologics is planning a second filing for its dual …
R&D
Sponsored
Rare Disease Diagnostics: Advancing Orphan Drug Development through Precision Testing
This white paper is free and can be downloaded and read at your …
News
Study points to route for 'one and done' flu vaccine
Scientists in the US have developed a new universal form of influenza …
News
IT outage raises resilience, security concerns in healthcare
Health systems around the world are dealing with cancelled …
News
NICE backs first 'take at home' prostate cancer pill
Thousands of men in the UK with advanced hormone-sensitive prostate …
News
GSK files Blenrep in EU, seeking return to market
Less than two years after pulling multiple myeloma therapy Blenrep …
Digital
Sponsored
Understanding PDURS: A new era for digital health and pharma
The FDA's Prescription Drug Use-Related Software (PDURS) framework …
News
FDA launches innovation hub to spur rare disease R&D
The FDA has said it will create a rare disease innovation hub to help …
Oncology
Chimeric antigen receptor T-cells: Emerging uses and future directions
Genetic engineering technologies allow for the creation of …
News
France warns of penalties if Opella production goes offshore
Sanofi is now in exclusive talks with private equity company Clayton Dubilier & Rice over the sale of a controlling stake in its consumer health business Opella, as the French governmen
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
R&D
Partner Content
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
